Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 4
1986 2
1987 2
1993 1
1994 3
1995 3
1996 1
1997 1
1998 4
1999 3
2000 1
2001 3
2002 5
2004 5
2005 2
2006 9
2007 5
2008 5
2009 10
2010 6
2011 1
2012 2
2013 3
2014 2
2015 5
2016 8
2017 9
2018 7
2019 2
2020 5
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Mixed germ cell tumor of central nervous system"
Page 1
Treatment of Pediatric Low-Grade Gliomas.
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA. Sait SF, et al. Curr Neurol Neurosci Rep. 2023 Apr;23(4):185-199. doi: 10.1007/s11910-023-01257-3. Epub 2023 Mar 7. Curr Neurol Neurosci Rep. 2023. PMID: 36881254 Free PMC article. Review.
PURPOSE OF REVIEW: Pediatric low-grade gliomas and glioneuronal tumors (pLGG) account for approximately 30% of pediatric CNS neoplasms, encompassing a heterogeneous group of tumors of primarily glial or mixed neuronal-glial histology. ...The success of molecular tar …
PURPOSE OF REVIEW: Pediatric low-grade gliomas and glioneuronal tumors (pLGG) account for approximately 30% of pediatric CNS neoplasms …
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council. van den Bent MJ, et al. Lancet. 2005 Sep 17-23;366(9490):985-90. doi: 10.1016/S0140-6736(05)67070-5. Lancet. 2005. PMID: 16168780 Clinical Trial.
BACKGROUND: Postoperative policies of "wait-and-see" and radiotherapy for low-grade glioma are poorly defined. A trial in the mid 1980s established the radiation dose. In 1986 the EORTC Radiotherapy and Brain Tumor Groups initiated a prospective trial to comp …
BACKGROUND: Postoperative policies of "wait-and-see" and radiotherapy for low-grade glioma are poorly defined. A trial in the mid 198 …
Malignant gliomas.
Burton EC, Prados MD. Burton EC, et al. Curr Treat Options Oncol. 2000 Dec;1(5):459-68. doi: 10.1007/s11864-000-0073-2. Curr Treat Options Oncol. 2000. PMID: 12057153 Review.
Gliomas are a heterogeneous group of neoplasms that comprise the majority of tumors originating in the central nervous system (CNS). ...Tumors of mixed lineage are also seen, the most common of which is designated anaplastic oligoastrocytoma (AO …
Gliomas are a heterogeneous group of neoplasms that comprise the majority of tumors originating in the central nervous …
Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors.
Abu Arja MH, Stanek JR, Finlay JL, AbdelBaki MS. Abu Arja MH, et al. Childs Nerv Syst. 2018 Nov;34(11):2179-2186. doi: 10.1007/s00381-018-3940-5. Epub 2018 Aug 3. Childs Nerv Syst. 2018. PMID: 30076436 Review.
BACKGROUND: The lack of a standard treatment approach has contributed to poor outcomes of patients with recurrent central nervous system (CNS) mixed malignant germ cell tumors (MMGCT). ...Six (17%) responses were reported as complete or c …
BACKGROUND: The lack of a standard treatment approach has contributed to poor outcomes of patients with recurrent central nervous …
Pinealoblastomas in children.
Cuccia V, Rodríguez F, Palma F, Zuccaro G. Cuccia V, et al. Childs Nerv Syst. 2006 Jun;22(6):577-85. doi: 10.1007/s00381-006-0095-6. Epub 2006 Mar 23. Childs Nerv Syst. 2006. PMID: 16555075 Clinical Trial.
INTRODUCTION: Series of pinealoblastomas (PB) usually comprise small number of cases as this tumor type is extremely rare and occurs mainly in childhood (especially under 9 years of age). ...MATERIALS AND METHODS: Our series of CNS pediatric tumors comprises 1,350 cases of …
INTRODUCTION: Series of pinealoblastomas (PB) usually comprise small number of cases as this tumor type is extremely rare and occurs …
Novel drug delivery strategies in neuro-oncology.
Bidros DS, Vogelbaum MA. Bidros DS, et al. Neurotherapeutics. 2009 Jul;6(3):539-46. doi: 10.1016/j.nurt.2009.04.004. Neurotherapeutics. 2009. PMID: 19560743 Free PMC article. Review.
Clinical trials using these methods have been completed, with mixed results, and several more are being initiated. In this review, we describe the clinically available methods used to circumvent the blood brain barrier and summarize the results to date of ongoing an …
Clinical trials using these methods have been completed, with mixed results, and several more are being initiated. In this rev …
Diffusely infiltrative low-grade gliomas in adults.
Lang FF, Gilbert MR. Lang FF, et al. J Clin Oncol. 2006 Mar 10;24(8):1236-45. doi: 10.1200/JCO.2005.05.2399. J Clin Oncol. 2006. PMID: 16525178 Review.
However, there is little consensus about the optimal treatment strategy for diffusely infiltrative LGGs, and the clinical management of LGGs is one of the most controversial areas in neurooncology. ...This article reviews the most recent data regarding the treatment of LGG …
However, there is little consensus about the optimal treatment strategy for diffusely infiltrative LGGs, and the clinical management …
Predictors of clinical outcome in pediatric oligodendroglioma: meta-analysis of individual patient data and multiple imputation.
Wang KY, Vankov ER, Lin DDM. Wang KY, et al. J Neurosurg Pediatr. 2018 Feb;21(2):153-163. doi: 10.3171/2017.7.PEDS17133. Epub 2017 Dec 1. J Neurosurg Pediatr. 2018. PMID: 29192869 Review.
Both univariate and multivariate analyses were performed. The multivariate model was adjusted for age, sex, tumor grade, mixed pathologies, extent of resection, chemotherapy, radiation therapy, tumor location, and initial presentation. ...Multivariate Cox reg …
Both univariate and multivariate analyses were performed. The multivariate model was adjusted for age, sex, tumor grade, mixed …
Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Pruitt R, DaSilva NS, Cappellano A, Belessiotis C, Diez B, Gardner S, Allen J, Weinblatt M, Gottardo N, Dhall G, Finlay JL. Pruitt R, et al. Pediatr Blood Cancer. 2015 Nov;62(11):1920-4. doi: 10.1002/pbc.25606. Epub 2015 Jun 5. Pediatr Blood Cancer. 2015. PMID: 26054044
OBJECTIVES: To evaluate patterns of relapse and outcome in patients newly diagnosed with CNS Mixed Malignant GCT (MMGCT) treated initially with chemotherapy alone. ...RESULTS: Thirteen patients at diagnosis had CNS MMGCT by pathology and tumor markers (n = 11), or …
OBJECTIVES: To evaluate patterns of relapse and outcome in patients newly diagnosed with CNS Mixed Malignant GCT (MMGCT) treated init …
Pituitary Function after High-Dose 177Lu-DOTATATE Therapy and Long-Term Follow-Up.
Sundlöv A, Sjögreen-Gleisner K, Tennvall J, Dahl L, Svensson J, Åkesson A, Bernhardt P, Lindgren O. Sundlöv A, et al. Neuroendocrinology. 2021;111(4):344-353. doi: 10.1159/000507761. Epub 2020 Apr 8. Neuroendocrinology. 2021. PMID: 32259830 Free PMC article. Clinical Trial.
OBJECTIVE: To study changes in pituitary function in patients with neuroendocrine tumors (NETs) treated with dosimetry-based 177Lu-DOTATATE to detect possible late toxicity. METHODS: 68 patients from a phase II clinical trial of dosimetry-based, individualized 177Lu …
OBJECTIVE: To study changes in pituitary function in patients with neuroendocrine tumors (NETs) treated with dosimetry-based 177Lu-DOTATATE …
111 results